GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (OTCPK:RHHBF) » Definitions » Cyclically Adjusted PS Ratio

Roche Holding AG (Roche Holding AG) Cyclically Adjusted PS Ratio : 2.88 (As of Apr. 27, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Roche Holding AG Cyclically Adjusted PS Ratio?

As of today (2024-04-27), Roche Holding AG's current share price is $255.60. Roche Holding AG's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 was $88.72. Roche Holding AG's Cyclically Adjusted PS Ratio for today is 2.88.

The historical rank and industry rank for Roche Holding AG's Cyclically Adjusted PS Ratio or its related term are showing as below:

RHHBF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.15   Med: 4.92   Max: 6.4
Current: 3.18

During the past 13 years, Roche Holding AG's highest Cyclically Adjusted PS Ratio was 6.40. The lowest was 3.15. And the median was 4.92.

RHHBF's Cyclically Adjusted PS Ratio is ranked worse than
65.76% of 736 companies
in the Drug Manufacturers industry
Industry Median: 2.06 vs RHHBF: 3.18

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Roche Holding AG's adjusted revenue per share data of for the fiscal year that ended in Dec23 was $86.928. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $88.72 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Roche Holding AG Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Roche Holding AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Cyclically Adjusted PS Ratio Chart

Roche Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.38 5.22 6.08 4.35 3.51

Roche Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.08 - 4.35 - 3.51

Competitive Comparison of Roche Holding AG's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Roche Holding AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Roche Holding AG's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's Cyclically Adjusted PS Ratio falls into.



Roche Holding AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Roche Holding AG's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=255.60/88.72
=2.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roche Holding AG's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Roche Holding AG's adjusted Revenue per Share data for the fiscal year that ended in Dec23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=86.928/106.4611*106.4611
=86.928

Current CPI (Dec23) = 106.4611.

Roche Holding AG Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 56.389 100.704 59.613
201512 56.128 99.386 60.123
201612 57.690 99.380 61.801
201712 62.792 100.213 66.707
201812 66.640 100.906 70.309
201912 72.401 101.063 76.268
202012 75.895 100.241 80.605
202112 79.288 101.776 82.938
202212 87.433 104.666 88.932
202312 86.928 106.461 86.928

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Roche Holding AG  (OTCPK:RHHBF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Roche Holding AG Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Roche Holding AG (Roche Holding AG) Business Description

Address
Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Roche Holding AG (Roche Holding AG) Headlines

From GuruFocus